Advanced Health Intelligence (ASX:AHI) received a US patent for its technology used in assessing disease risks from user-captured images, according to a Jan. 10 filing with the Australian bourse.
The technology enables the analysis of user images to assess risks for metabolic, cardiovascular, and obesity-related diseases, providing users with a comprehensive risk assessment that can guide healthcare professionals in early diagnosis and intervention, the filing said.
The patent covers the process in which digital images, such as body shape and biometric data, are captured and analyzed to identify health risks.
The patent also provides exclusive protection for these methods, preventing third-party replication and reinforcing the company's competitive edge in the rapidly growing health tech sector, the filing said.
The digital health solutions provider plans to extend its patent coverage globally, with a focus on telehealth, population screening, and insurance, per the filing.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。